FMC Corp

FMC Corp(FMC)股票分析

$8.090

-0.214 (-2.65%)收盤時

Loading chart…
最高
8.320
開盤
8.220
成交量加權均價
8.15
成交量
3.03M
市值
7.12B
最低
8.035
成交金額
24.69M
企業價值/稅息折舊攤銷前利潤(TTM)
7.29

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.

AI 分析 of FMC Corp (FMC)

賣出

FMC Corp is not a good buy right now due to its current price of $8.35 being significantly below the lowest analyst target of $10 and a troubling RSI of 24.247 indicating oversold conditions. The company's financial performance shows a staggering 71.73% decline over the past year, and its debt-to-equity ratio is alarmingly high at 257.70%, indicating potential financial instability. The main risk is the ongoing net losses, with a net income of -186600000 in Q2 2026, which raises concerns about the company's ability to recover and generate profits in the near future.

分析師評級(21)

上檔空間 +135.85%
買進
13 買進
8 持有
0 賣出
目前: 8.09
最低
13.00
平均
19.08
最高
28.00

BMO Capital

2026-10-06

目標價

$11

Market Perform

UBS

2026-10-05

目標價

$10

中性

Seaport Research

2026-08-04

目標價

$21

買進

RBC Capital

2026-08-03

目標價

$11

Sector Perform

Morgan Stanley

2026-07-31

目標價

$12

Equal Weight

估值指標

FMC Corp(FMC)目前預期本益比為 5.66,5 年平均預期本益比為 14.26。

預期本益比

低估
5 年均值 P/E
14.26
目前P/E
5.66
高估
20.02
低估
8.50

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
2.40
目前EV/EBITDA
7.29
高估
45.67
低估
-40.87

預期股價營收比

低估
5 年均值 P/S
1.73
目前P/S
0.34
高估
2.61
低估
0.84

Alphio AI 對 FMC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%FMC

$44.59

情境價格

基

基準

基準 · 50%FMC

$42.71

情境價格

悲

悲觀

悲觀 · 25%FMC

$40.23

情境價格

持有 FMC 的大戶

H

HBK Investments L.P.

+ 持有FMC

+1.25%

3個月報酬率

事件時間軸

2026-09-23 (ET)

16:30:00

Tessenderlo Group Invests $403M in FMC

2026-09-17 (ET)

08:00:00

AgroSpheres and FMC Advance Bioinsecticide Candidates

2026-08-25 (ET)

07:30:00

BofA Resumes Coverage of FMC with Neutral Rating and $12 Price Target

2026-07-29 (ET)

18:00:00

Company Sees Q3 Revenue of $840M-$900M

18:00:00

Company Sees Q4 Revenue of $1.06B-$1.2B

資訊

FMC 常見問題 —— 由 Alphio AI 解答

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).

FMC Corp is not a good buy right now due to its current price of $8.35 being significantly below the lowest analyst target of $10 and a troubling RSI of 24.247 indicating oversold conditions. The company's financial performance shows a staggering 71.73% decline over the past year, and its debt-to-equity ratio is alarmingly high at 257.70%, indicating potential financial instability. The main risk is the ongoing net losses, with a net income of -186600000 in Q2 2026, which raises concerns about the company's ability to recover and generate profits in the near future.

21 analysts cover FMC: 13 rate it Buy, 8 Hold and 0 Sell. The average price target is 19.08.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始